Literature DB >> 33803434

Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype.

Makedonka Atanasovska Velkovska1, Katja Goričar2, Tanja Blagus2, Vita Dolžan2, Barbara Cvenkel1,3.   

Abstract

Oxidative stress and neuroinflammation are involved in the pathogenesis and progression of glaucoma. Our aim was to evaluate the impact of selected single-nucleotide polymorphisms in inflammation and oxidative stress genes on the risk of glaucoma, the patients' clinical characteristics and the glaucoma phenotype. In total, 307 patients with primary open-angle glaucoma or ocular hypertension were enrolled. The control group included 339 healthy Slovenian blood donors. DNA was isolated from peripheral blood. Genotyping was performed for SOD2 rs4880, CAT rs1001179, GPX1 rs1050450, GSTP1 rs1695, GSTM1 gene deletion, GSTT1 gene deletion, IL1B rs1143623, IL1B rs16944, IL6 rs1800795 and TNF rs1800629. We found a nominally significant association of GSTM1 gene deletion with decreased risk of ocular hypertension and a protective role of IL1B rs16944 and IL6 rs1800629 in the risk of glaucoma. The CT and TT genotypes of GPX1 rs1050450 were significantly associated with advanced disease, lower intraocular pressure and a larger vertical cup-disc ratio. In conclusion, genetic variability in IL1B and IL6 may be associated with glaucoma risk, while GPX and TNF may be associated with the glaucoma phenotype. In the future, improved knowledge of these pathways has the potential for new strategies and personalised treatment of glaucoma.

Entities:  

Keywords:  glaucoma; inflammation; oxidative stress; phenotype; polymorphism; susceptibility

Year:  2021        PMID: 33803434      PMCID: PMC7967191          DOI: 10.3390/jcm10051148

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

1.  Updates in Clinical and Translational Glaucoma Research.

Authors:  José Javier García-Medina; Maria Dolores Pinazo-Durán
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

2.  Mechanism of Secondary Glaucoma Development in HTLV-1 Uveitis.

Authors:  Yuan Zong; Koju Kamoi; Naoko Ando; Hisako Kurozumi-Karube; Kyoko Ohno-Matsui
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

Review 3.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.